Viewing Study NCT07222332


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2025-12-25 @ 7:15 PM
Study NCT ID: NCT07222332
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-10-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module